Jonathan Yong
Stock Analyst at UBS
(2.62)
# 2,112
Out of 4,876 analysts
104
Total ratings
60%
Success rate
10.49%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $9.5 → $7 | $4.19 | +67.06% | 5 | May 8, 2025 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $2.74 | +46.25% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $20.67 | +11.27% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $21.78 | +14.78% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.44 | +162.24% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $9.56 | +25.52% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.96 | +61.45% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $13.11 | +98.32% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $50.32 | -72.18% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $73.60 | +30.43% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $15.33 | +108.74% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $21.33 | +392.26% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $122.34 | -34.61% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $260.72 | -11.40% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $98.09 | +2.97% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $8.61 | +213.59% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $166.93 | -40.09% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $728.64 | -38.24% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $3.79 | +216.62% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.81 | +796.77% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $14.91 | +14.02% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $293.69 | +19.17% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $21.74 | +336.98% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $5.83 | +45.80% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $22.00 | +86.36% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $8.39 | +102.62% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.48 | +144.25% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $81.63 | +4.13% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $178.79 | -18.34% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $53.77 | +97.14% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $180.85 | -13.19% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $330.21 | +11.44% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $240.20 | +164.36% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $68.41 | +71.03% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $13.76 | +118.02% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $382.14 | -22.02% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $175.64 | -45.91% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $305.76 | +61.89% | 1 | Oct 15, 2021 |
eHealth
May 8, 2025
Maintains: Neutral
Price Target: $9.5 → $7
Current: $4.19
Upside: +67.06%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $2.74
Upside: +46.25%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $20.67
Upside: +11.27%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $21.78
Upside: +14.78%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.44
Upside: +162.24%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $9.56
Upside: +25.52%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.96
Upside: +61.45%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $13.11
Upside: +98.32%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $50.32
Upside: -72.18%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $73.60
Upside: +30.43%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.33
Upside: +108.74%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $21.33
Upside: +392.26%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $122.34
Upside: -34.61%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $260.72
Upside: -11.40%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $98.09
Upside: +2.97%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $8.61
Upside: +213.59%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $166.93
Upside: -40.09%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $728.64
Upside: -38.24%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $3.79
Upside: +216.62%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.81
Upside: +796.77%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $14.91
Upside: +14.02%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $293.69
Upside: +19.17%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $21.74
Upside: +336.98%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $5.83
Upside: +45.80%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.00
Upside: +86.36%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $8.39
Upside: +102.62%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.48
Upside: +144.25%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $81.63
Upside: +4.13%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $178.79
Upside: -18.34%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $53.77
Upside: +97.14%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $180.85
Upside: -13.19%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $330.21
Upside: +11.44%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $240.20
Upside: +164.36%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $68.41
Upside: +71.03%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $13.76
Upside: +118.02%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $382.14
Upside: -22.02%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $175.64
Upside: -45.91%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $305.76
Upside: +61.89%